SELLAS Life Sciences (SLS) Current Assets (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Current Assets for 9 consecutive years, with $24.0 million as the latest value for Q3 2024.
- On a quarterly basis, Current Assets changed N/A to $24.0 million in Q3 2024 year-over-year; TTM through Sep 2024 was $24.0 million, a N/A change, with the full-year FY2023 number at $3.2 million, changed N/A from a year prior.
- Current Assets was $24.0 million for Q3 2024 at SELLAS Life Sciences, up from $3.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $36.9 million in Q4 2020 to a low of $3.2 million in Q4 2023.
- A 5-year average of $21.3 million and a median of $23.0 million in 2021 define the central range for Current Assets.
- Peak YoY movement for Current Assets: plummeted 61.67% in 2020, then soared 561.22% in 2021.
- SELLAS Life Sciences' Current Assets stood at $36.9 million in 2020, then crashed by 37.59% to $23.0 million in 2021, then dropped by 1.91% to $22.6 million in 2022, then tumbled by 85.97% to $3.2 million in 2023, then soared by 657.72% to $24.0 million in 2024.
- Per Business Quant, the three most recent readings for SLS's Current Assets are $24.0 million (Q3 2024), $3.2 million (Q4 2023), and $22.6 million (Q3 2022).